{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:33:09Z","timestamp":1780497189964,"version":"3.54.1"},"reference-count":49,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rehabilitation (Stuttg)"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Patienten mit pAVK sind hinsichtlich der Verordnungsh\u00e4ufigkeit von Reha-Ma\u00dfnahmen\n                    [1] und der Kontrolle der Risikofaktoren im Vergleich zu Patienten mit koronarer\n                    Herzerkrankung (KHK) bei Haus\u00e4rzten schlechter eingestellt [2\u20134]. Sie erkennen\n                    das erh\u00f6hte kardiovaskul\u00e4re Risiko und die damit verbundene Notwendigkeit einer\n                    Lebensstil\u00e4nderung und Therapietreue nicht in dem Ma\u00dfe wie Patienten mit KHK\n                    [5]. Dieser Beitrag widmet sich der Frage, warum die Entwicklung spezialisierter\n                    gef\u00e4\u00dfmedizinischer Versorgungsstrukturen angestrebt wurde und wie sich dies zu\n                    einem eigenst\u00e4ndigen Gebiet der Rehabilitation weiterentwickeln kann und sollte.\n                <\/jats:p>","DOI":"10.1055\/a-2154-3672","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:09:52Z","timestamp":1733962192000},"page":"376-388","source":"Crossref","is-referenced-by-count":1,"title":["Gef\u00e4\u00dfmedizinische Rehabilitation bei Patienten mit peripher\n                    arterieller Verschlusskrankheit (pAVK)Von der spezialisierten Form zur eigenen\n                    Fachabteilung"],"prefix":"10.1055","volume":"63","author":[{"given":"Gesine","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/a-0620-6911","article-title":"Rehabilitation of Patients with Peripheral Arterial Disease in the Context of\n                    Guideline Recommendations","volume":"58","author":"J Falk","year":"2019","journal-title":"Rehabilitation (Stuttg)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"8295054","DOI":"10.1155\/2019\/8295054","article-title":"Burden of Coronary Artery","volume":"2019","author":"R Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial\n                    disease","volume":"326","author":"M H Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e007332","DOI":"10.1161\/JAHA.117.007332","article-title":"Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral\n                    Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis\n                    Risk in Communities) Study","volume":"7","author":"C A Kalbaugh","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major\n                    adverse cardiovascular events and major adverse limb events among patients with\n                    peripheral arterial disease","volume":"3","author":"E J Armstrong","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0021-9150(03)00204-1","article-title":"High prevalence of peripheral arterial disease and co-morbidity in 6880 primary\n                    care patients: cross-sectional study","volume":"172","author":"C Diehm","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/eurheartj\/ehl092","article-title":"Association of low ankle brachial index with high mortality in primary care","volume":"27","author":"C Diehm","year":"2006","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","article-title":"A global and regional burden of death and disability from peripheral artery\n                    disease 21 World Regions, 1990 to 2010","volume":"9","author":"UK A Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/clc.22721","article-title":"Geographic variation and risk factors for systemic and limb ischemic events in\n                    patients with symptomatic peripheral artery disease: Insights from the REACH\n                    Registry","volume":"40","author":"J Abtan","year":"2017","journal-title":"Clin Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ahj.2013.12.016","article-title":"Association of the ankle-brachial index with history of myocardial infarction\n                    and stroke","volume":"167","author":"W S Jones","year":"2014","journal-title":"Am Heart"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of High and Low Ankle Brachial Index to All-Cause and\n                    Cardiovascular Disease Mortality: The Strong Heart Study","volume":"109","author":"H E Resnick","year":"2004","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk\n                    of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"ref13","first-page":"152","article-title":"Antithrombotische Therapie bei PAVK","volume":"10","author":"M Hirschl","year":"2003","journal-title":"J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both\n                    men and women: results from a nationwide study","volume":"22","author":"S Subherwal","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force\n                    for the management of arterial hypertension of the European Society of\n                    Hypertension: Endorsed by the International Society of Hypertension (ISH) and\n                    the European Renal Association (ERA)","volume":"41","author":"G Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","article-title":"The effect of intensified lipid-lowering therapy on long-term prognosis in\n                    patients with peripheral arterial disease","volume":"45","author":"HH H Feringa","year":"2007","journal-title":"J Vasc Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of Statin Dose With Amputation and Survival in Patients With\n                    Peripheral Artery Disease","volume":"137","author":"S Arya","year":"2018","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in\n                    Patients With Peripheral Artery Disease \u2013 Insights From the FOURIER Trial","volume":"137","author":"M P Bonaca","year":"2018","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1177\/2047487318770299","article-title":"Peripheral arterial disease: Changes in clinical outcomes and therapeutic\n                    strategies in two cohorts, from 2002 to 2008 and from 2008 to 2014. A\n                    population-based study","volume":"25","author":"M Baviere","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"ref22","first-page":"111","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"ref23","first-page":"280","article-title":"Medication-based secondary prevention in patients with peripheral arterial\n                    occlusive disease: An analysis based on secondary data","volume":"46","author":"K Gebauer","year":"2021","journal-title":"Herz"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"99e107","DOI":"10.1016\/j.atherosclerosis.2017.11.020","article-title":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol\n                    goal attainment in patients at high and very-high cardiovascular risk:\n                    Real-world evidence from Germany","volume":"268","author":"W M\u00e4rz","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed Opportunities Despite Improvement in Use of Cardioprotective Medications\n                    Among Patients With Lower-Extremity Peripheral Artery Disease, Underuse\n                    Remains","volume":"126","author":"S Subherwal","year":"2012","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","article-title":"Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a\n                    consensus document from the ESC working group on aorta and peripheral vascular\n                    diseases, the ESC working group on thrombosis, and the ESC working group on\n                    cardiovascular pharmacotherapy","volume":"42","author":"V Aboyans","year":"2021","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"M P Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1055\/a-1954-8578","article-title":"Antithrombotic Therapy in Lower Extremity Arterial Disease and Aortic\n                    Diseases","volume":"11","author":"C Espinola-Klein","year":"2022","journal-title":"Aktuel Kardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or\n                    carotid artery disease: an international, randomised, double-blind,\n                    placebo-controlled trial","volume":"391","author":"S S Anand","year":"2018","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.jacc.2014.03.039","article-title":"Antithrombotic treatment in patients with heart failure and associated atrial\n                    fibrillation and vascular disease: a nationwide cohort study","volume":"63","author":"M Lamberts","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve\n                    Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial\n                    Disease","volume":"151","author":"M A Hussain","year":"2016","journal-title":"JAMA Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/eurheartj\/ehad734","article-title":"Exercise therapy for chronic symptomatic peripheral artery disease","volume":"45","author":"L Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological Treatment and Current Management of Peripheral Artery\n                    Disease","volume":"116","author":"M P Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"CD005263","DOI":"10.1002\/14651858.CD005263.pub4","article-title":"Supervised exersice therapy versus walking advice for intermittent\n                    claudication","volume":"4","author":"D Hagemann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.jvs.2021.03.063","article-title":"An updated systematic review and meta-analysis of home-based exercise programs\n                    for individuals with intermittent claudication","volume":"74","author":"S Pymer","year":"2021","journal-title":"J Vasc Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bjsports-2018-100205","article-title":"Resistance training as a treatment for older persons with peripheral artery\n                    disease: a systematic review and meta-analysis","volume":"54","author":"B J Parmenter","year":"2020","journal-title":"Br J Sports Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"CD009638","DOI":"10.1002\/14651858.CD009638.pub3","article-title":"Modes of exercise training for intermittent claudication","volume":"8","author":"SC P Jansen","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jvs.2022.04.045","article-title":"A systematic review on smartphone use for activity monitoring during exercise\n                    therapy in intermittent claudication","volume":"76","author":"C Veiga","year":"2022","journal-title":"J Vasc Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jvs.2011.11.123","article-title":"Optimal exercise program length for patients with claudication: a randomized\n                    controlled trail","volume":"55","author":"A W Gardener","year":"2012","journal-title":"J Vasc Surg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1358863X14559092","article-title":"Exercise training for health-related quality of life in peripheral artery\n                    disease: A systematic review and meta-analysis","volume":"20","author":"B J Parmenter","year":"2015","journal-title":"Vasc Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvs.2018.10.069","article-title":"A systematic review and meta-analysis of the effects of supervised exercise\n                    therapy on modifiable cardiovascular risk factors in intermittent\n                    claudication","volume":"69","author":"SC P Jansen","year":"2019","journal-title":"J Vasc Surg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1253\/circj.CJ-08-0141","article-title":"Patients with peripheral artery disease who complete a 12-week exersice training\n                    program show a reduced cardiovacular mortality and morbidity","volume":"73","author":"S Sakamoto","year":"2009","journal-title":"Circ J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1024\/0301-1526\/a001057","article-title":"A prospective survey study on the education and awareness about walking exercise\n                    amongst inpatients with symptomatic peripheral arterial disease in Germany","volume":"52","author":"Y Li","year":"2023","journal-title":"Vasa"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1024\/0301-1526\/a001071","article-title":"How German vascular surgeons and angiologists judge walking exercise for\n                    patients with PAD Results from a nationwide survey amongst 743 members of two\n                    major scientific societies","volume":"52","author":"U Rother","year":"2023","journal-title":"Vasa"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00772-020-00677-6","article-title":"Krankenhausinzidenz, station\u00e4re Versorgung und Outcome der peripheren\n                    arteriellen Verschlusskrankheit und arteriellen Thrombose\/Embolie in Deutschland\n                    von 2005 bis 2018","volume":"25","author":"A K\u00fchnl","year":"2020","journal-title":"Gef\u00e4sschirurgie"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization an supervised exercise for peripheral artery\n                    disease and intermittent claudication \u2013 an randomized clinical trial","volume":"314","author":"F Fakhry","year":"2015","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1097\/SLA.0000000000004712","article-title":"Long-term follow-up of randomized clinical trial comparing endovascular\n                    revascularization plus supervised exercise with supervised exercise only in\n                    intermittent claudication","volume":"276","author":"S Klaphake","year":"2022","journal-title":"Ann Surg"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e008450","DOI":"10.1161\/CIRCINTERVENTIONS.119.008450","article-title":"Absence of Long-Term Benefit of Revascularization in Patients with Intermittent\n                    Claudication Five-Year Results From the IRONIC Randomized Controlled Trial","volume":"13","author":"H Djerf","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1358863X13505861","article-title":"Psychosocial outcome in cardiovascular rehabilitation of peripheral artery\n                    disease and coronary artery disease patients, 2013","volume":"18","author":"S Stauber","year":"2013","journal-title":"Vasc Med"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-61379-5","volume-title":"Hrsg. Klinische Angiologie","author":"U Hoffmann","year":"2025"},{"key":"ref52","first-page":"289","article-title":"Reha-Verlaufseffekte bei Rehabilitand:innen mit peripherer arterieller\n                    Verschlusskrankheit zum Rehabilitationsende","volume":"130","author":"K Meng","year":"2024","journal-title":"DRV-Schriften"}],"container-title":["Die Rehabilitation"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2154-3672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:10:44Z","timestamp":1733962244000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2154-3672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2024,12,11]]},"published-print":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2154-3672","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0034-3536","1439-1309"],"issn-type":[{"value":"0034-3536","type":"print"},{"value":"1439-1309","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}